| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.577 | 0.031 | 0.577 | Analgesic | |||
| 0.551 | 0.016 | 0.584 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.584 0.009 DBMET01777 0.533 0.021 DBMET00328 | DBMET01777 | |
| 0.486 | 0.035 | 0.586 | Aldehyde oxidase inhibitor | 0.409 0.046 DBMET01777 0.586 0.021 DBMET00328 | DBMET00328 | |
| 0.48 | 0.039 | 0.496 | 5 Hydroxytryptamine release inhibitor | 0.496 0.034 DBMET01777 0.441 0.056 DBMET00328 | DBMET01777 | |
| 0.47 | 0.035 | 0.585 | GABA C receptor rho-3 antagonist | 0.585 0.009 DBMET01777 0.567 0.012 DBMET00328 | DBMET01777 | |
| 0.435 | 0.003 | 0.435 | Opioid delta receptor agonist | |||
| 0.405 | 0.02 | 0.405 | Peroxidase inhibitor | 0.318 0.034 DBMET01777 0.405 0.02 DBMET00328 | ||
| 0.385 | 0.017 | 0.449 | 5 Hydroxytryptamine uptake stimulant | 0.449 0.007 DBMET01777 0.388 0.016 DBMET00328 | DBMET01777 | |
| 0.365 | 0.025 | 0.365 | Interleukin agonist | 0.26 0.071 DBMET01777 0.246 0.081 DBMET00328 | ||
| 0.364 | 0.028 | 0.364 | Sigma receptor agonist | 0.126 0.107 DBMET01777 | ||
| 0.345 | 0.017 | 0.383 | Tyrosine 3 hydroxylase inhibitor | 0.383 0.01 DBMET01777 0.358 0.014 DBMET00328 | DBMET01777 | |
| 0.331 | 0.005 | 0.331 | Analgesic, opioid | |||
| 0.349 | 0.037 | 0.571 | Superoxide dismutase inhibitor | 0.282 0.057 DBMET01777 0.571 0.008 DBMET00328 | DBMET00328 | |
| 0.364 | 0.053 | 0.517 | 5 Hydroxytryptamine release stimulant | 0.517 0.025 DBMET01777 0.477 0.031 DBMET00328 | DBMET01777 | |
| 0.313 | 0.004 | 0.313 | TRPA1 agonist | 0.213 0.008 DBMET01777 0.198 0.011 DBMET00328 | ||
| 0.381 | 0.072 | 0.381 | Prostaglandin dehydrogenase inhibitor | 0.272 0.116 DBMET01777 | ||
| 0.326 | 0.028 | 0.326 | Anesthetic general | 0.201 0.074 DBMET01777 0.247 0.051 DBMET00328 | ||
| 0.317 | 0.02 | 0.317 | 5 Hydroxytryptamine 1E antagonist | 0.276 0.049 DBMET01777 0.223 0.105 DBMET00328 | ||
| 0.345 | 0.053 | 0.345 | Calcium channel activator | 0.312 0.08 DBMET01777 0.344 0.054 DBMET00328 | ||
| 0.308 | 0.028 | 0.349 | Gastrin inhibitor | 0.349 0.011 DBMET01777 0.239 0.092 DBMET00328 | DBMET01777 | |
| 0.392 | 0.116 | 0.446 | Caspase 9 stimulant | 0.351 0.144 DBMET01777 0.446 0.085 DBMET00328 | DBMET00328 | |
| 0.295 | 0.021 | 0.295 | Neuropeptide Y2 antagonist | 0.275 0.034 DBMET01777 0.193 0.133 DBMET00328 | ||
| 0.276 | 0.006 | 0.308 | Porphobilinogen synthase inhibitor | 0.166 0.017 DBMET01777 0.308 0.005 DBMET00328 | DBMET00328 | |
| 0.279 | 0.015 | 0.279 | Anesthetic local | 0.232 0.024 DBMET01777 0.129 0.061 DBMET00328 | ||
| 0.322 | 0.062 | 0.322 | Spasmolytic | 0.222 0.104 DBMET01777 | ||
| 0.282 | 0.03 | 0.282 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.243 0.046 DBMET01777 0.22 0.058 DBMET00328 | ||
| 0.286 | 0.04 | 0.286 | MAP kinase kinase 2 inhibitor | 0.284 0.041 DBMET01777 | ||
| 0.267 | 0.023 | 0.367 | Nitric-oxide synthase stimulant | 0.367 0.004 DBMET01777 0.263 0.025 DBMET00328 | DBMET01777 | |
| 0.295 | 0.059 | 0.295 | Cardiotonic | 0.263 0.074 DBMET01777 | ||
| 0.296 | 0.061 | 0.339 | Insulysin inhibitor | 0.339 0.038 DBMET01777 0.265 0.083 DBMET00328 | DBMET01777 | |
| 0.249 | 0.013 | 0.367 | Ferrochelatase inhibitor | 0.224 0.017 DBMET01777 0.367 0.004 DBMET00328 | DBMET00328 | |
| 0.279 | 0.048 | 0.279 | Psychostimulant | 0.279 0.048 DBMET01777 0.169 0.101 DBMET00328 | ||
| 0.251 | 0.029 | 0.251 | Cytidine deaminase inhibitor | 0.132 0.089 DBMET01777 0.114 0.107 DBMET00328 | ||
| 0.334 | 0.121 | 0.334 | Beta lactamase inhibitor | 0.319 0.127 DBMET01777 | ||
| 0.233 | 0.021 | 0.601 | Aldehyde dehydrogenase inhibitor | 0.188 0.031 DBMET01777 0.601 0.004 DBMET00328 | DBMET00328 | |
| 0.237 | 0.025 | 0.816 | Alpha-N-acetylglucosaminidase inhibitor | 0.263 0.021 DBMET01777 0.816 0.002 DBMET00328 | DBMET00328 | |
| 0.281 | 0.07 | 0.281 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.256 0.076 DBMET01777 | ||
| 0.23 | 0.019 | 0.241 | ATPase inhibitor | 0.241 0.016 DBMET01777 0.209 0.031 DBMET00328 | DBMET01777 | |
| 0.214 | 0.005 | 0.214 | Opioid agonist | |||
| 0.321 | 0.113 | 0.359 | Histamine release inhibitor | 0.329 0.109 DBMET01777 0.359 0.096 DBMET00328 | DBMET00328 | |
| 0.312 | 0.107 | 0.475 | Calpain 2 inhibitor | 0.475 0.031 DBMET01777 0.406 0.058 DBMET00328 | DBMET01777 | |
| 0.228 | 0.029 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.251 0.015 DBMET01777 0.263 0.011 DBMET00328 | DBMET00328 | |
| 0.219 | 0.028 | 0.306 | Nav1.2 sodium channel blocker | 0.306 0.014 DBMET01777 | DBMET01777 | |
| 0.214 | 0.026 | 0.214 | Toll-Like receptor antagonist | 0.108 0.106 DBMET01777 | ||
| 0.285 | 0.1 | 0.325 | Vasodilator, coronary | 0.325 0.069 DBMET01777 0.27 0.114 DBMET00328 | DBMET01777 | |
| 0.215 | 0.031 | 0.259 | Heat shock protein 90 antagonist | 0.259 0.018 DBMET01777 | DBMET01777 | |
| 0.193 | 0.012 | 0.193 | Opioid delta receptor antagonist | |||
| 0.319 | 0.145 | 0.355 | Transcription factor inhibitor | 0.355 0.128 DBMET01777 | DBMET01777 | |
| 0.277 | 0.106 | 0.318 | Cholesterol antagonist | 0.259 0.119 DBMET01777 0.318 0.08 DBMET00328 | DBMET00328 | |
| 0.191 | 0.034 | 0.326 | GABA C receptor rho-2 antagonist | 0.326 0.004 DBMET01777 0.237 0.014 DBMET00328 | DBMET01777 | |
| 0.257 | 0.102 | 0.257 | Nootropic | |||
| 0.224 | 0.069 | 0.277 | RNA-directed DNA polymerase inhibitor | 0.209 0.086 DBMET01777 0.277 0.037 DBMET00328 | DBMET00328 | |
| 0.159 | 0.004 | 0.159 | TRPM8 blocker | 0.051 0.015 DBMET01777 | ||
| 0.267 | 0.113 | 0.346 | Thyroid hormone antagonist | 0.346 0.075 DBMET01777 | DBMET01777 | |
| 0.263 | 0.11 | 0.342 | Thyroid hormone beta antagonist | 0.342 0.071 DBMET01777 | DBMET01777 | |
| 0.266 | 0.114 | 0.301 | Antithrombotic | 0.233 0.141 DBMET01777 0.301 0.087 DBMET00328 | DBMET00328 | |
| 0.17 | 0.018 | 0.17 | Beta glucuronidase inhibitor | 0.096 0.076 DBMET01777 0.11 0.056 DBMET00328 | ||
| 0.184 | 0.033 | 0.215 | CF transmembrane conductance regulator agonist | 0.215 0.015 DBMET01777 0.177 0.039 DBMET00328 | DBMET01777 | |
| 0.25 | 0.1 | 0.3 | Ca(v)3.3 blocker | 0.3 0.042 DBMET01777 | DBMET01777 | |
| 0.17 | 0.02 | 0.17 | Opioid antagonist | 0.077 0.073 DBMET01777 | ||
| 0.198 | 0.05 | 0.265 | Heat shock protein 90 alpha antagonist | 0.265 0.022 DBMET01777 0.124 0.12 DBMET00328 | DBMET01777 | |
| 0.19 | 0.043 | 0.195 | Death-associated protein kinase 2 inhibitor | 0.195 0.038 DBMET01777 | DBMET01777 | |
| 0.171 | 0.026 | 0.171 | Calcium channel N-type blocker | 0.144 0.042 DBMET01777 | ||
| 0.149 | 0.005 | 0.149 | Kinesin antagonist | 0.04 0.023 DBMET01777 | ||
| 0.149 | 0.005 | 0.149 | Kinesin-like protein 1 inhibitor | 0.04 0.023 DBMET01777 | ||
| 0.219 | 0.076 | 0.221 | MAP kinase kinase 3 inhibitor | 0.221 0.072 DBMET01777 | DBMET01777 | |
| 0.189 | 0.047 | 0.189 | MAP kinase kinase 5 inhibitor | 0.169 0.088 DBMET01777 | ||
| 0.146 | 0.004 | 0.184 | Estrogen-related receptor beta agonist | 0.184 0.003 DBMET01777 0.106 0.018 DBMET00328 | DBMET01777 | |
| 0.204 | 0.063 | 0.226 | Histone acetyltransferase inhibitor | 0.226 0.039 DBMET01777 | DBMET01777 | |
| 0.185 | 0.045 | 0.185 | Neurotensin receptor agonist | 0.175 0.055 DBMET01777 0.162 0.075 DBMET00328 | ||
| 0.173 | 0.035 | 0.209 | Nav1.3 sodium channel blocker | 0.209 0.022 DBMET01777 0.1 0.097 DBMET00328 | DBMET01777 | |
| 0.235 | 0.098 | 0.242 | Transcription factor STAT inhibitor | 0.242 0.092 DBMET01777 0.198 0.141 DBMET00328 | DBMET01777 | |
| 0.174 | 0.037 | 0.21 | Toll-Like receptor 2 antagonist | 0.21 0.019 DBMET01777 0.158 0.047 DBMET00328 | DBMET01777 | |
| 0.219 | 0.087 | 0.219 | Antiamyloidogenic | |||
| 0.16 | 0.03 | 0.175 | Sphingosine 1-phosphate receptor 2 antagonist | 0.175 0.018 DBMET01777 0.138 0.059 DBMET00328 | DBMET01777 | |
| 0.222 | 0.093 | 0.303 | Calpain inhibitor | 0.303 0.029 DBMET01777 0.279 0.042 DBMET00328 | DBMET01777 | |
| 0.164 | 0.037 | 0.223 | Cathepsin H inhibitor | 0.169 0.034 DBMET01777 0.223 0.017 DBMET00328 | DBMET00328 | |
| 0.156 | 0.029 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.147 0.051 DBMET01777 0.183 0.006 DBMET00328 | DBMET00328 | |
| 0.149 | 0.024 | 0.149 | Transcription factor STAT6 inhibitor | 0.138 0.034 DBMET01777 0.103 0.097 DBMET00328 | ||
| 0.144 | 0.019 | 0.192 | NADH dehydrogenase inhibitor | 0.105 0.039 DBMET01777 0.192 0.011 DBMET00328 | DBMET00328 | |
| 0.185 | 0.067 | 0.185 | Lipocortins synthesis antagonist | |||
| 0.142 | 0.023 | 0.16 | Electrolyte absorption antagonist | 0.155 0.018 DBMET01777 0.16 0.016 DBMET00328 | DBMET00328 | |
| 0.124 | 0.006 | 0.124 | Orexin receptor antagonist | 0.071 0.038 DBMET01777 | ||
| 0.144 | 0.027 | 0.144 | Sphingomyelinase inhibitor | 0.142 0.028 DBMET01777 0.102 0.058 DBMET00328 | ||
| 0.161 | 0.044 | 0.161 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.071 DBMET01777 0.15 0.061 DBMET00328 | ||
| 0.167 | 0.051 | 0.277 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 DBMET01777 0.277 0.008 DBMET00328 | DBMET00328 | |
| 0.139 | 0.025 | 0.139 | Interleukin 2 antagonist | 0.109 0.066 DBMET01777 | ||
| 0.284 | 0.171 | 0.364 | Calcium channel L-type activator | 0.364 0.107 DBMET01777 | DBMET01777 | |
| 0.139 | 0.027 | 0.182 | Prolactin inhibitor | 0.125 0.035 DBMET01777 0.182 0.012 DBMET00328 | DBMET00328 | |
| 0.182 | 0.07 | 0.182 | Amyloid beta precursor protein antagonist | 0.159 0.092 DBMET00328 | ||
| 0.136 | 0.025 | 0.423 | Triose-phosphate isomerase inhibitor | 0.12 0.032 DBMET01777 0.423 0.003 DBMET00328 | DBMET00328 | |
| 0.189 | 0.079 | 0.189 | Focal adhesion kinase 2 inhibitor | 0.168 0.102 DBMET01777 | ||
| 0.193 | 0.083 | 0.216 | Neurotrophic factor enhancer | 0.206 0.071 DBMET01777 0.216 0.062 DBMET00328 | DBMET00328 | |
| 0.114 | 0.008 | 0.139 | Phospholipase D inhibitor | 0.139 0.004 DBMET01777 0.091 0.021 DBMET00328 | DBMET01777 | |
| 0.129 | 0.024 | 0.129 | Histamine N-methyltransferase inhibitor | 0.076 0.072 DBMET01777 0.091 0.054 DBMET00328 | ||
| 0.112 | 0.008 | 0.112 | Orexin receptor 1 antagonist | 0.069 0.057 DBMET01777 | ||
| 0.187 | 0.083 | 0.187 | I kappa B kinase epsilon inhibitor | 0.175 0.095 DBMET01777 | ||
| 0.151 | 0.047 | 0.151 | Cyclooxygenase 3 inhibitor | 0.139 0.058 DBMET01777 0.137 0.06 DBMET00328 | ||
| 0.127 | 0.023 | 0.127 | Opioid mu receptor antagonist | |||
| 0.109 | 0.006 | 0.153 | Potassium channel (Tandem pore domain) blocker | 0.153 0.004 DBMET01777 0.08 0.035 DBMET00328 | DBMET01777 | |
| 0.121 | 0.019 | 0.121 | Bile acid receptor antagonist | 0.101 0.047 DBMET01777 0.086 0.083 DBMET00328 | ||
| 0.14 | 0.039 | 0.14 | Chelator | 0.104 0.071 DBMET01777 | ||
| 0.132 | 0.032 | 0.132 | Acetylcholine release stimulant | 0.122 0.046 DBMET01777 0.12 0.048 DBMET00328 | ||
| 0.174 | 0.075 | 0.445 | Succinate dehydrogenase inhibitor | 0.181 0.067 DBMET01777 0.445 0.004 DBMET00328 | DBMET00328 | |
| 0.114 | 0.02 | 0.144 | Granulocyte macrophage colony stimulating factor agonist | 0.105 0.029 DBMET01777 0.144 0.006 DBMET00328 | DBMET00328 | |
| 0.13 | 0.037 | 0.13 | Gastric antisecretory | 0.116 0.046 DBMET01777 | ||
| 0.097 | 0.004 | 0.097 | Benzodiazepine antagonist | 0.054 0.02 DBMET01777 | ||
| 0.152 | 0.059 | 0.178 | Adenylate cyclase stimulant | 0.178 0.028 DBMET01777 0.177 0.029 DBMET00328 | DBMET01777 | |
| 0.107 | 0.015 | 0.107 | CC chemokine 5 receptor agonist | 0.098 0.024 DBMET01777 0.088 0.04 DBMET00328 | ||
| 0.203 | 0.113 | 0.203 | DNA damaging | 0.188 0.126 DBMET01777 | ||
| 0.182 | 0.092 | 0.192 | Pyruvate kinase inhibitor | 0.192 0.086 DBMET00328 | DBMET00328 | |
| 0.106 | 0.018 | 0.106 | Cannabinoid CB1 receptor agonist | 0.093 0.022 DBMET01777 | ||
| 0.093 | 0.005 | 0.102 | Adenylate cyclase 1 inhibitor | 0.102 0.004 DBMET01777 0.065 0.014 DBMET00328 | DBMET01777 | |
| 0.221 | 0.134 | 0.221 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.13 | 0.044 | 0.232 | GABA C receptor antagonist | 0.232 0.008 DBMET01777 0.212 0.011 DBMET00328 | DBMET01777 | |
| 0.13 | 0.044 | 0.365 | GABA C receptor agonist | 0.139 0.039 DBMET01777 0.365 0.006 DBMET00328 | DBMET00328 | |
| 0.115 | 0.029 | 0.127 | CYP2A6 inhibitor | 0.11 0.031 DBMET01777 0.127 0.024 DBMET00328 | DBMET00328 | |
| 0.122 | 0.038 | 0.233 | GABA C receptor rho-1 antagonist | 0.233 0.005 DBMET01777 0.184 0.011 DBMET00328 | DBMET01777 | |
| 0.094 | 0.011 | 0.094 | Toll-Like receptor 8 antagonist | |||
| 0.087 | 0.005 | 0.087 | Orexin receptor 2 antagonist | |||
| 0.096 | 0.016 | 0.122 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.122 0.005 DBMET01777 0.093 0.019 DBMET00328 | DBMET01777 | |
| 0.132 | 0.053 | 0.141 | Sphingosine 1-phosphate receptor 4 antagonist | 0.141 0.042 DBMET01777 0.131 0.055 DBMET00328 | DBMET01777 | |
| 0.12 | 0.041 | 0.186 | Creatine kinase inhibitor | 0.103 0.057 DBMET01777 0.186 0.013 DBMET00328 | DBMET00328 | |
| 0.128 | 0.049 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.123 0.053 DBMET01777 0.141 0.04 DBMET00328 | DBMET00328 | |
| 0.082 | 0.005 | 0.082 | Diamine oxidase inhibitor | 0.066 0.008 DBMET01777 | ||
| 0.106 | 0.03 | 0.106 | Opioid kappa receptor antagonist | |||
| 0.102 | 0.027 | 0.125 | Aminopeptidase I inhibitor | 0.105 0.025 DBMET01777 0.125 0.018 DBMET00328 | DBMET00328 | |
| 0.1 | 0.026 | 0.1 | Cannabinoid receptor agonist | 0.069 0.042 DBMET01777 | ||
| 0.095 | 0.021 | 0.095 | Secretase beta inhibitor | 0.091 0.025 DBMET01777 | ||
| 0.118 | 0.044 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 DBMET01777 0.432 0.004 DBMET00328 | DBMET00328 | |
| 0.088 | 0.015 | 0.088 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.088 0.015 DBMET01777 | ||
| 0.093 | 0.02 | 0.162 | Biliverdin reductase inhibitor | 0.077 0.028 DBMET01777 0.162 0.008 DBMET00328 | DBMET00328 | |
| 0.12 | 0.047 | 0.12 | Electron transport complex I inhibitor | 0.101 0.079 DBMET01777 | ||
| 0.081 | 0.011 | 0.081 | Bcl-xL inhibitor | 0.061 0.038 DBMET01777 | ||
| 0.084 | 0.014 | 0.098 | Corticotropin releasing factor 2 receptor antagonist | 0.098 0.007 DBMET01777 0.062 0.042 DBMET00328 | DBMET01777 | |
| 0.154 | 0.084 | 0.212 | Arachidonic acid antagonist | 0.153 0.085 DBMET01777 0.212 0.023 DBMET00328 | DBMET00328 | |
| 0.11 | 0.042 | 0.136 | Glutamate (mGluR7) agonist | 0.136 0.018 DBMET01777 0.104 0.051 DBMET00328 | DBMET01777 | |
| 0.128 | 0.06 | 0.128 | Acetylcholine muscarinic antagonist | 0.101 0.09 DBMET01777 | ||
| 0.073 | 0.006 | 0.073 | 5-Alpha-reductase 2 inhibitor | 0.017 0.016 DBMET01777 | ||
| 0.2 | 0.133 | 0.236 | Transcription factor STAT3 inhibitor | 0.236 0.096 DBMET01777 0.218 0.113 DBMET00328 | DBMET01777 | |
| 0.071 | 0.005 | 0.098 | Delayed rectifier potassium channel blocker | 0.098 0.004 DBMET01777 | DBMET01777 | |
| 0.099 | 0.033 | 0.117 | Glycine receptor antagonist | 0.08 0.056 DBMET01777 0.117 0.02 DBMET00328 | DBMET00328 | |
| 0.137 | 0.071 | 0.137 | Calcium channel blocker | 0.112 0.098 DBMET01777 | ||
| 0.255 | 0.189 | 0.283 | DNA polymerase beta inhibitor | 0.283 0.174 DBMET01777 | DBMET01777 | |
| 0.07 | 0.004 | 0.07 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.092 | 0.026 | 0.117 | Glycine receptor agonist | 0.075 0.045 DBMET01777 0.117 0.014 DBMET00328 | DBMET00328 | |
| 0.075 | 0.009 | 0.11 | Glutamate (mGluR1a) antagonist | 0.11 0.005 DBMET01777 | DBMET01777 | |
| 0.14 | 0.075 | 0.145 | Heat shock protein 70 antagonist | 0.139 0.08 DBMET01777 0.145 0.059 DBMET00328 | DBMET00328 | |
| 0.126 | 0.061 | 0.181 | Proteasome inhibitor | 0.181 0.032 DBMET01777 0.16 0.041 DBMET00328 | DBMET01777 | |
| 0.12 | 0.056 | 0.12 | Calcium channel (voltage-sensitive) blocker | 0.107 0.074 DBMET01777 | ||
| 0.077 | 0.013 | 0.077 | 5-Alpha-reductase inhibitor | |||
| 0.078 | 0.014 | 0.078 | 5 Hydroxytryptamine 7 agonist | 0.056 0.039 DBMET01777 | ||
| 0.103 | 0.039 | 0.103 | Bcr-Abl kinase inhibitor | 0.101 0.04 DBMET01777 | ||
| 0.083 | 0.019 | 0.14 | Heat shock protein 90 beta antagonist | 0.14 0.005 DBMET01777 | DBMET01777 | |
| 0.128 | 0.064 | 0.16 | Papain-like protease (SARS coronavirus) inhibitor | 0.16 0.026 DBMET01777 | DBMET01777 | |
| 0.125 | 0.061 | 0.186 | Cholesterol synthesis inhibitor | 0.186 0.03 DBMET00328 | DBMET00328 | |
| 0.139 | 0.076 | 0.146 | Pregnane X receptor agonist | 0.133 0.091 DBMET01777 0.146 0.061 DBMET00328 | DBMET00328 | |
| 0.108 | 0.045 | 0.359 | Alcohol dehydrogenase inhibitor | 0.092 0.061 DBMET01777 0.359 0.004 DBMET00328 | DBMET00328 | |
| 0.077 | 0.014 | 0.097 | Epithelial sodium channel blocker | 0.097 0.007 DBMET01777 | DBMET01777 | |
| 0.135 | 0.073 | 0.135 | Nav1.6 sodium channel blocker | 0.112 0.108 DBMET01777 0.114 0.105 DBMET00328 | ||
| 0.081 | 0.02 | 0.235 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 DBMET01777 0.235 0.005 DBMET00328 | DBMET00328 | |
| 0.067 | 0.006 | 0.067 | 5-Alpha-reductase 1 inhibitor | |||
| 0.143 | 0.083 | 0.143 | Diuretic | 0.14 0.086 DBMET01777 | ||
| 0.09 | 0.031 | 0.114 | Phenylalanine 4-hydroxylase inhibitor | 0.066 0.05 DBMET01777 0.114 0.02 DBMET00328 | DBMET00328 | |
| 0.081 | 0.022 | 0.172 | Acyl-CoA dehydrogenase inhibitor | 0.077 0.024 DBMET01777 0.172 0.007 DBMET00328 | DBMET00328 | |
| 0.129 | 0.07 | 0.129 | Acetylcholinesterase inhibitor | |||
| 0.112 | 0.054 | 0.155 | Urease inhibitor | 0.155 0.021 DBMET01777 0.087 0.081 DBMET00328 | DBMET01777 | |
| 0.111 | 0.053 | 0.111 | Butyrylcholinesterase inhibitor | |||
| 0.138 | 0.082 | 0.197 | Thiol protease inhibitor | 0.159 0.061 DBMET01777 0.197 0.04 DBMET00328 | DBMET00328 | |
| 0.13 | 0.075 | 0.13 | Alkaline phosphatase inhibitor | 0.12 0.086 DBMET01777 | ||
| 0.079 | 0.025 | 0.079 | NMDA 2C receptor antagonist | 0.056 0.051 DBMET01777 | ||
| 0.109 | 0.055 | 0.356 | Adenylate kinase inhibitor | 0.1 0.067 DBMET01777 0.356 0.004 DBMET00328 | DBMET00328 | |
| 0.095 | 0.042 | 0.095 | Glutathione S-transferase inhibitor | 0.088 0.05 DBMET01777 0.087 0.052 DBMET00328 | ||
| 0.247 | 0.194 | 0.278 | MAP kinase kinase 6 inhibitor | 0.278 0.158 DBMET01777 | DBMET01777 | |
| 0.152 | 0.098 | 0.287 | 3C-like protease (Human coronavirus) inhibitor | 0.193 0.056 DBMET01777 0.287 0.014 DBMET00328 | DBMET00328 | |
| 0.068 | 0.015 | 0.068 | Squalene epoxidase inhibitor | 0.059 0.021 DBMET00328 | ||
| 0.09 | 0.037 | 0.122 | Cathepsin G inhibitor | 0.107 0.031 DBMET01777 0.122 0.027 DBMET00328 | DBMET00328 | |
| 0.09 | 0.037 | 0.17 | Glutamate dehydrogenase inhibitor | 0.087 0.039 DBMET01777 0.17 0.013 DBMET00328 | DBMET00328 | |
| 0.08 | 0.028 | 0.099 | Glutamate (mGluR7) antagonist | 0.062 0.061 DBMET01777 0.099 0.011 DBMET00328 | DBMET00328 | |
| 0.213 | 0.161 | 0.221 | Vasodilator, peripheral | 0.221 0.153 DBMET00328 | DBMET00328 | |
| 0.062 | 0.011 | 0.062 | Plasmepsin II inhibitor | 0.046 0.021 DBMET01777 | ||
| 0.21 | 0.159 | 0.29 | Transcription factor NF kappa B inhibitor | 0.197 0.172 DBMET01777 0.29 0.1 DBMET00328 | DBMET00328 | |
| 0.19 | 0.139 | 0.359 | DNA synthesis inhibitor | 0.238 0.076 DBMET01777 0.359 0.028 DBMET00328 | DBMET00328 | |
| 0.168 | 0.117 | 0.168 | Potassium channel blocker | |||
| 0.138 | 0.088 | 0.139 | Phospholipase A2 inhibitor | 0.139 0.087 DBMET00328 | DBMET00328 | |
| 0.078 | 0.028 | 0.117 | Exportin-1 inhibitor | 0.073 0.037 DBMET01777 0.117 0.005 DBMET00328 | DBMET00328 | |
| 0.073 | 0.024 | 0.094 | Histone deacetylase SIRT3 inhibitor | 0.094 0.012 DBMET01777 0.058 0.056 DBMET00328 | DBMET01777 | |
| 0.11 | 0.061 | 0.2 | Falcipain 3 inhibitor | 0.172 0.027 DBMET01777 0.2 0.018 DBMET00328 | DBMET00328 | |
| 0.101 | 0.052 | 0.133 | Potassium channel (Voltage-sensitive) activator | 0.133 0.021 DBMET01777 | DBMET01777 | |
| 0.107 | 0.059 | 0.117 | Carbonic anhydrase XV inhibitor | 0.117 0.049 DBMET01777 0.114 0.052 DBMET00328 | DBMET01777 | |
| 0.074 | 0.027 | 0.074 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.14 | 0.093 | 0.173 | Interferon gamma antagonist | 0.129 0.112 DBMET01777 0.173 0.055 DBMET00328 | DBMET00328 | |
| 0.139 | 0.092 | 0.2 | Hexokinase inhibitor | 0.127 0.108 DBMET01777 0.2 0.035 DBMET00328 | DBMET00328 | |
| 0.074 | 0.028 | 0.074 | Cannabinoid CB2 receptor agonist | |||
| 0.099 | 0.054 | 0.211 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.093 0.061 DBMET01777 0.211 0.014 DBMET00328 | DBMET00328 | |
| 0.11 | 0.065 | 0.134 | Mucolytic | 0.128 0.048 DBMET01777 0.134 0.043 DBMET00328 | DBMET00328 | |
| 0.081 | 0.038 | 0.098 | Vanilloid 4 agonist | 0.087 0.03 DBMET01777 0.098 0.019 DBMET00328 | DBMET00328 | |
| 0.123 | 0.08 | 0.131 | Vanilloid 1 agonist | 0.131 0.064 DBMET01777 0.131 0.065 DBMET00328 | DBMET00328 | |
| 0.061 | 0.019 | 0.061 | Neurokinin 2 antagonist | |||
| 0.072 | 0.03 | 0.117 | Purinergic P2X1 antagonist | 0.06 0.043 DBMET01777 0.117 0.012 DBMET00328 | DBMET00328 | |
| 0.197 | 0.155 | 0.206 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 DBMET00328 | DBMET00328 | |
| 0.172 | 0.13 | 0.172 | ErbB-1 antagonist | |||
| 0.079 | 0.038 | 0.112 | Sphingosine 1-phosphate receptor 4 agonist | 0.112 0.019 DBMET01777 0.075 0.04 DBMET00328 | DBMET01777 | |
| 0.139 | 0.098 | 0.21 | Melanin inhibitor | 0.152 0.078 DBMET01777 0.21 0.037 DBMET00328 | DBMET00328 | |
| 0.101 | 0.06 | 0.144 | Anabolic | 0.088 0.081 DBMET01777 0.144 0.021 DBMET00328 | DBMET00328 | |
| 0.133 | 0.092 | 0.133 | Acetylcholine M1 receptor antagonist | |||
| 0.132 | 0.092 | 0.15 | Hemostatic | 0.15 0.068 DBMET01777 | DBMET01777 | |
| 0.065 | 0.025 | 0.065 | Ryanodine receptor antagonist | 0.06 0.037 DBMET01777 0.062 0.032 DBMET00328 | ||
| 0.103 | 0.063 | 0.212 | Aminopeptidase B inhibitor | 0.113 0.057 DBMET01777 0.212 0.019 DBMET00328 | DBMET00328 | |
| 0.073 | 0.033 | 0.113 | Protease 3C (Human rhinovirus) inhibitor | 0.102 0.015 DBMET01777 0.113 0.011 DBMET00328 | DBMET00328 | |
| 0.098 | 0.059 | 0.106 | MAP kinase kinase 1 inhibitor | 0.106 0.05 DBMET01777 | DBMET01777 | |
| 0.206 | 0.167 | 0.206 | Thioredoxin glutathione reductase inhibitor | |||
| 0.053 | 0.015 | 0.053 | Substance P antagonist | |||
| 0.081 | 0.043 | 0.244 | Glutamate decarboxylase inhibitor | 0.075 0.049 DBMET01777 0.244 0.005 DBMET00328 | DBMET00328 | |
| 0.091 | 0.054 | 0.091 | Androgen antagonist | |||
| 0.088 | 0.05 | 0.088 | GABA A receptor agonist | |||
| 0.054 | 0.017 | 0.058 | Guanylate cyclase inhibitor | 0.058 0.014 DBMET00328 | DBMET00328 | |
| 0.26 | 0.222 | 0.317 | MAP kinase 1 inhibitor | 0.317 0.163 DBMET01777 | DBMET01777 | |
| 0.041 | 0.005 | 0.041 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET01777 0.03 0.016 DBMET00328 | ||
| 0.174 | 0.137 | 0.25 | Immunostimulant | 0.158 0.148 DBMET01777 0.25 0.096 DBMET00328 | DBMET00328 | |
| 0.04 | 0.003 | 0.046 | Estrogen-related receptor gamma agonist | 0.046 0.003 DBMET01777 | DBMET01777 | |
| 0.106 | 0.07 | 0.106 | GABA receptor agonist | |||
| 0.114 | 0.079 | 0.114 | Cholinergic antagonist | |||
| 0.133 | 0.098 | 0.133 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.08 | 0.045 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 DBMET01777 0.081 0.043 DBMET00328 | DBMET01777 | |
| 0.092 | 0.057 | 0.12 | Glutamate release inhibitor | 0.094 0.053 DBMET01777 0.12 0.022 DBMET00328 | DBMET00328 | |
| 0.045 | 0.01 | 0.045 | Liver X receptor beta antagonist | |||
| 0.054 | 0.019 | 0.054 | Neuraminidase (Influenza A) inhibitor | |||
| 0.073 | 0.039 | 0.073 | Bcl2 antagonist | |||
| 0.074 | 0.04 | 0.084 | Acetylcholine M5 receptor agonist | 0.084 0.031 DBMET01777 0.081 0.033 DBMET00328 | DBMET01777 | |
| 0.144 | 0.111 | 0.144 | DNA methyltransferase I inhibitor | 0.135 0.123 DBMET01777 | ||
| 0.054 | 0.021 | 0.054 | Cytokine production stimulant | 0.05 0.028 DBMET01777 0.053 0.023 DBMET00328 | ||
| 0.064 | 0.031 | 0.064 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.133 | 0.101 | 0.153 | MAP kinase 3 inhibitor | 0.153 0.063 DBMET01777 | DBMET01777 | |
| 0.146 | 0.115 | 0.184 | Phospholipase C inhibitor | 0.145 0.117 DBMET01777 0.184 0.057 DBMET00328 | DBMET00328 | |
| 0.053 | 0.022 | 0.053 | Oxytocin agonist | 0.049 0.024 DBMET01777 0.051 0.023 DBMET00328 | ||
| 0.066 | 0.035 | 0.084 | Carbonic anhydrase stimulant | 0.084 0.024 DBMET01777 0.058 0.043 DBMET00328 | DBMET01777 | |
| 0.052 | 0.021 | 0.073 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET01777 0.073 0.006 DBMET00328 | DBMET00328 | |
| 0.041 | 0.011 | 0.041 | Adenosine uptake inhibitor | 0.035 0.022 DBMET01777 | ||
| 0.081 | 0.051 | 0.104 | Interferon agonist | 0.071 0.069 DBMET01777 0.104 0.026 DBMET00328 | DBMET00328 | |
| 0.057 | 0.027 | 0.057 | Neurokinin antagonist | |||
| 0.056 | 0.027 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.109 | 0.08 | 0.109 | Acetylcholine antagonist | |||
| 0.138 | 0.11 | 0.166 | Antipruritic | 0.166 0.077 DBMET01777 | DBMET01777 | |
| 0.065 | 0.037 | 0.087 | TRPA1 antagonist | 0.076 0.028 DBMET01777 0.087 0.022 DBMET00328 | DBMET00328 | |
| 0.077 | 0.05 | 0.102 | GABA aminotransferase inhibitor | 0.076 0.052 DBMET01777 0.102 0.025 DBMET00328 | DBMET00328 | |
| 0.069 | 0.041 | 0.087 | Histone deacetylase inhibitor | 0.087 0.025 DBMET01777 | DBMET01777 | |
| 0.092 | 0.065 | 0.092 | MAO B inhibitor | 0.088 0.068 DBMET01777 | ||
| 0.058 | 0.031 | 0.058 | DNA helicase inhibitor | 0.058 0.03 DBMET01777 | ||
| 0.048 | 0.021 | 0.048 | Liver X receptor alpha agonist | |||
| 0.065 | 0.039 | 0.065 | Calcium channel P-type blocker | 0.063 0.045 DBMET00328 | ||
| 0.108 | 0.083 | 0.126 | MAO inhibitor | 0.126 0.071 DBMET01777 | DBMET01777 | |
| 0.086 | 0.06 | 0.13 | Ornithine decarboxylase inhibitor | 0.111 0.033 DBMET01777 0.13 0.019 DBMET00328 | DBMET00328 | |
| 0.086 | 0.062 | 0.122 | Bromodomain-containing protein 2 inhibitor | 0.122 0.022 DBMET01777 0.09 0.055 DBMET00328 | DBMET01777 | |
| 0.083 | 0.059 | 0.099 | D-Ala-D-Ala ligase inhibitor | 0.086 0.052 DBMET01777 0.099 0.03 DBMET00328 | DBMET00328 | |
| 0.058 | 0.035 | 0.08 | Pregnane X receptor antagonist | 0.054 0.047 DBMET01777 0.08 0.006 DBMET00328 | DBMET00328 | |
| 0.058 | 0.035 | 0.058 | Acetylcholine muscarinic agonist | 0.054 0.039 DBMET01777 | ||
| 0.062 | 0.039 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.065 0.033 DBMET01777 0.067 0.03 DBMET00328 | DBMET00328 | |
| 0.125 | 0.102 | 0.125 | Cholinergic | |||
| 0.105 | 0.083 | 0.148 | Caspase 3 inhibitor | 0.115 0.067 DBMET01777 0.148 0.029 DBMET00328 | DBMET00328 | |
| 0.055 | 0.032 | 0.106 | Aconitate hydratase inhibitor | 0.063 0.023 DBMET01777 0.106 0.007 DBMET00328 | DBMET00328 | |
| 0.059 | 0.037 | 0.072 | Potassium channel Kv1.5 blocker | 0.072 0.028 DBMET01777 | DBMET01777 | |
| 0.114 | 0.091 | 0.158 | Antibacterial (Helicobacter pylori) | 0.158 0.04 DBMET01777 | DBMET01777 | |
| 0.061 | 0.039 | 0.061 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.049 DBMET01777 | ||
| 0.061 | 0.04 | 0.061 | Acetylcholine M3 receptor antagonist | |||
| 0.05 | 0.029 | 0.102 | Potassium channel Kv1.3 blocker | 0.102 0.008 DBMET01777 0.042 0.039 DBMET00328 | DBMET01777 | |
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET00328 | ||
| 0.049 | 0.029 | 0.073 | Thymidylate synthase inhibitor | 0.073 0.01 DBMET01777 0.051 0.026 DBMET00328 | DBMET01777 | |
| 0.053 | 0.032 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.025 DBMET01777 0.057 0.027 DBMET00328 | DBMET01777 | |
| 0.063 | 0.042 | 0.063 | Acetylcholine M2 receptor antagonist | |||
| 0.044 | 0.024 | 0.044 | Neurokinin 1 antagonist | |||
| 0.087 | 0.067 | 0.1 | Potassium channel (Ca-activated) activator | 0.1 0.055 DBMET01777 | DBMET01777 | |
| 0.045 | 0.025 | 0.054 | Histone deacetylase 8 inhibitor | 0.054 0.02 DBMET01777 | DBMET01777 | |
| 0.097 | 0.077 | 0.141 | Alpha 2b adrenoreceptor antagonist | 0.141 0.043 DBMET01777 | DBMET01777 | |
| 0.035 | 0.016 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 DBMET01777 | ||
| 0.026 | 0.007 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET01777 0.022 0.011 DBMET00328 | ||
| 0.049 | 0.03 | 0.049 | CC chemokine 4 receptor antagonist | |||
| 0.092 | 0.073 | 0.115 | Nitric-oxide synthase inhibitor | 0.115 0.041 DBMET01777 | DBMET01777 | |
| 0.027 | 0.008 | 0.027 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.024 | 0.007 | 0.024 | Toll-Like receptor 8 agonist | |||
| 0.076 | 0.059 | 0.076 | Acetylcholine nicotinic antagonist | |||
| 0.045 | 0.029 | 0.045 | Acetylcholine M1 receptor agonist | 0.04 0.032 DBMET01777 | ||
| 0.034 | 0.018 | 0.034 | Cholesterol ester transfer protein antagonist | 0.029 0.025 DBMET01777 | ||
| 0.024 | 0.008 | 0.028 | Apolipoprotein B-100 inhibitor | 0.028 0.007 DBMET01777 | DBMET01777 | |
| 0.044 | 0.029 | 0.052 | Histamine H1 receptor agonist | 0.052 0.016 DBMET01777 0.049 0.02 DBMET00328 | DBMET01777 | |
| 0.034 | 0.018 | 0.034 | Acetylcholine M4 receptor agonist | |||
| 0.043 | 0.028 | 0.048 | Nerve growth factor antagonist | 0.048 0.02 DBMET00328 | DBMET00328 | |
| 0.184 | 0.169 | 0.217 | 12-Lipoxygenase inhibitor | 0.217 0.133 DBMET01777 | DBMET01777 | |
| 0.061 | 0.046 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 DBMET01777 | DBMET01777 | |
| 0.027 | 0.013 | 0.042 | Glutamate (mGluR1) agonist | 0.042 0.005 DBMET01777 0.028 0.012 DBMET00328 | DBMET01777 | |
| 0.025 | 0.01 | 0.032 | Apolipoprotein B inhibitor | 0.032 0.007 DBMET01777 | DBMET01777 | |
| 0.06 | 0.045 | 0.06 | Transcription factor AP-1 inhibitor | |||
| 0.05 | 0.036 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.039 DBMET01777 0.061 0.021 DBMET00328 | DBMET00328 | |
| 0.033 | 0.018 | 0.033 | Plasmepsin I inhibitor | |||
| 0.224 | 0.209 | 0.278 | DNA directed DNA polymerase inhibitor | 0.278 0.174 DBMET01777 | DBMET01777 | |
| 0.035 | 0.021 | 0.035 | Liver X receptor beta agonist | |||
| 0.039 | 0.025 | 0.053 | Potassium channel Kv1.1 blocker | 0.053 0.012 DBMET01777 0.045 0.017 DBMET00328 | DBMET01777 | |
| 0.038 | 0.025 | 0.049 | Glucose-6-phosphate dehydrogenase inhibitor | 0.049 0.012 DBMET01777 | DBMET01777 | |
| 0.062 | 0.049 | 0.064 | Interferon inducer | 0.064 0.045 DBMET00328 | DBMET00328 | |
| 0.027 | 0.014 | 0.031 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 DBMET01777 0.031 0.01 DBMET00328 | DBMET00328 | |
| 0.113 | 0.1 | 0.127 | Protein kinase stimulant | 0.127 0.086 DBMET00328 | DBMET00328 | |
| 0.032 | 0.019 | 0.032 | LIM domain kinase 2 inhibitor | |||
| 0.035 | 0.023 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.024 | 0.012 | 0.024 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.016 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01777 0.015 0.007 DBMET00328 | DBMET01777 | |
| 0.035 | 0.024 | 0.035 | Gonadotropin-releasing hormone receptor antagonist | 0.033 0.025 DBMET01777 | ||
| 0.042 | 0.031 | 0.05 | Leukocyte elastase inhibitor | 0.05 0.024 DBMET01777 0.044 0.028 DBMET00328 | DBMET01777 | |
| 0.044 | 0.033 | 0.063 | Dihydroorotase inhibitor | 0.063 0.015 DBMET01777 0.042 0.036 DBMET00328 | DBMET01777 | |
| 0.046 | 0.035 | 0.056 | Glutamate (mGluR group I) agonist | 0.056 0.025 DBMET01777 0.049 0.031 DBMET00328 | DBMET01777 | |
| 0.043 | 0.032 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.026 DBMET01777 | DBMET01777 | |
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase inhibitor | |||
| 0.1 | 0.091 | 0.167 | Microtubule formation inhibitor | 0.117 0.064 DBMET01777 0.167 0.03 DBMET00328 | DBMET00328 | |
| 0.031 | 0.021 | 0.044 | Epoxide hydrolase 1 inhibitor | 0.044 0.009 DBMET01777 0.03 0.023 DBMET00328 | DBMET01777 | |
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | 0.016 0.013 DBMET01777 | ||
| 0.029 | 0.021 | 0.055 | Glucagon receptor antagonist | 0.055 0.009 DBMET01777 | DBMET01777 | |
| 0.014 | 0.005 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.046 | 0.037 | 0.046 | Cholesterol esterase inhibitor | |||
| 0.151 | 0.143 | 0.154 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.154 0.139 DBMET01777 | DBMET01777 | |
| 0.017 | 0.009 | 0.02 | CDK2/cyclin A3 inhibitor | 0.02 0.005 DBMET01777 | DBMET01777 | |
| 0.034 | 0.026 | 0.034 | Retinoid X receptor agonist | 0.031 0.028 DBMET00328 | ||
| 0.042 | 0.034 | 0.042 | Neurokinin 3 antagonist | |||
| 0.051 | 0.043 | 0.051 | Leukotriene B4 antagonist | |||
| 0.063 | 0.056 | 0.1 | Glutamate (mGluR6) antagonist | 0.1 0.01 DBMET00328 | DBMET00328 | |
| 0.028 | 0.021 | 0.041 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET01777 0.041 0.007 DBMET00328 | DBMET00328 | |
| 0.144 | 0.137 | 0.144 | Anticonvulsant | |||
| 0.021 | 0.014 | 0.023 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00328 | DBMET00328 | |
| 0.054 | 0.047 | 0.054 | Leukotriene C antagonist | |||
| 0.037 | 0.031 | 0.037 | MAP3K5 inhibitor | |||
| 0.022 | 0.016 | 0.041 | Glutamate (mGluR1a) agonist | 0.031 0.008 DBMET01777 0.041 0.005 DBMET00328 | DBMET00328 | |
| 0.051 | 0.045 | 0.853 | Alcohol oxidase inhibitor | 0.853 0.002 DBMET00328 | DBMET00328 | |
| 0.018 | 0.012 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | CXC chemokine receptor antagonist | |||
| 0.039 | 0.034 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.033 DBMET01777 0.06 0.007 DBMET00328 | DBMET00328 | |
| 0.088 | 0.083 | 0.09 | Phosphodiesterase 6D inhibitor | 0.09 0.077 DBMET01777 | DBMET01777 | |
| 0.077 | 0.072 | 0.113 | Histamine H2 receptor antagonist | 0.113 0.025 DBMET01777 | DBMET01777 | |
| 0.039 | 0.035 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.042 | 0.038 | 0.042 | Glutamate (mGluR5) agonist | 0.042 0.039 DBMET01777 | ||
| 0.091 | 0.088 | 0.161 | Cystathionine beta-synthase inhibitor | 0.161 0.036 DBMET00328 | DBMET00328 | |
| 0.025 | 0.021 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 DBMET01777 0.026 0.017 DBMET00328 | DBMET01777 | |
| 0.094 | 0.09 | 0.153 | Adenylate cyclase inhibitor | 0.153 0.043 DBMET01777 | DBMET01777 | |
| 0.01 | 0.007 | 0.01 | Angiotensin AT2 receptor agonist | |||
| 0.044 | 0.041 | 0.044 | Cannabinoid CB2 receptor antagonist | 0.043 0.042 DBMET01777 | ||
| 0.127 | 0.124 | 0.159 | LIM domain kinase 1 inhibitor | 0.159 0.09 DBMET01777 | DBMET01777 | |
| 0.013 | 0.01 | 0.02 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET00328 | DBMET00328 | |
| 0.036 | 0.034 | 0.036 | Aggrecanase 1 inhibitor | |||
| 0.023 | 0.02 | 0.028 | Methionyl aminopeptidase 2 inhibitor | 0.028 0.015 DBMET01777 | DBMET01777 | |
| 0.111 | 0.109 | 0.111 | Activin receptor-like kinase 2 inhibitor | |||
| 0.025 | 0.023 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.016 DBMET01777 | DBMET01777 | |
| 0.066 | 0.064 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.048 DBMET01777 | DBMET01777 | |
| 0.054 | 0.052 | 0.069 | NMDA receptor glycine site agonist | 0.06 0.046 DBMET01777 0.069 0.037 DBMET00328 | DBMET00328 | |
| 0.02 | 0.018 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.015 DBMET00328 | ||
| 0.037 | 0.036 | 0.039 | Thymidine kinase inhibitor | 0.037 0.036 DBMET01777 0.039 0.031 DBMET00328 | DBMET00328 | |
| 0.063 | 0.062 | 0.244 | Catalase inhibitor | 0.244 0.009 DBMET00328 | DBMET00328 | |
| 0.057 | 0.056 | 0.076 | Heme oxygenase stimulant | 0.076 0.018 DBMET01777 | DBMET01777 | |
| 0.052 | 0.051 | 0.08 | Sphingosine 1-phosphate receptor 3 antagonist | 0.08 0.017 DBMET01777 | DBMET01777 | |
| 0.03 | 0.029 | 0.03 | Growth hormone secretagogue receptor antagonist | |||
| 0.049 | 0.048 | 0.085 | CC chemokine 2 receptor antagonist | 0.085 0.017 DBMET01777 | DBMET01777 | |
| 0.044 | 0.043 | 0.054 | Potassium channel (Inward rectifier) blocker | 0.054 0.029 DBMET01777 | DBMET01777 | |
| 0.021 | 0.021 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DBMET01777 | DBMET01777 | |
| 0.034 | 0.034 | 0.04 | Retinoid X receptor antagonist | 0.04 0.024 DBMET00328 | DBMET00328 | |
| 0.023 | 0.023 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 DBMET00328 | DBMET00328 | |
| 0.047 | 0.048 | 0.068 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 DBMET00328 | DBMET00328 | |
| 0.043 | 0.043 | 0.144 | Glucose-6-phosphate isomerase inhibitor | 0.144 0.003 DBMET00328 | DBMET00328 | |
| 0.025 | 0.025 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 DBMET00328 | DBMET00328 | |
| 0.044 | 0.045 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.028 DBMET01777 | DBMET01777 | |
| 0.03 | 0.031 | 0.037 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET01777 0.037 0.014 DBMET00328 | DBMET00328 | |
| 0.03 | 0.032 | 0.036 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET00328 | DBMET00328 | |
| 0.03 | 0.032 | 0.036 | Retinoid X alpha receptor antagonist | 0.036 0.021 DBMET00328 | DBMET00328 | |
| 0.029 | 0.031 | 0.074 | Fumarate hydratase inhibitor | 0.074 0.008 DBMET00328 | DBMET00328 | |
| 0.019 | 0.021 | 0.024 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.024 0.006 DBMET01777 | DBMET01777 | |
| 0.06 | 0.062 | 0.081 | Cannabinoid receptor antagonist | 0.081 0.039 DBMET01777 | DBMET01777 | |
| 0.003 | 0.005 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 DBMET01777 | DBMET01777 | |
| 0.033 | 0.036 | 0.049 | Histone deacetylase class I inhibitor | 0.049 0.02 DBMET01777 | DBMET01777 | |
| 0.095 | 0.098 | 0.154 | Photosensitizer | 0.107 0.076 DBMET01777 0.154 0.029 DBMET00328 | DBMET00328 | |
| 0.063 | 0.066 | 0.074 | Rho-associated kinase I inhibitor | 0.074 0.052 DBMET01777 | DBMET01777 | |
| 0.044 | 0.047 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DBMET00328 | DBMET00328 | |
| 0.149 | 0.153 | 0.159 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.138 DBMET00328 | DBMET00328 | |
| 0.045 | 0.048 | 0.064 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET01777 0.052 0.031 DBMET00328 | DBMET01777 | |
| 0.077 | 0.082 | 0.103 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 DBMET00328 | DBMET00328 | |
| 0.043 | 0.047 | 0.06 | Potassium channel (ATP-sensitive) activator | 0.06 0.015 DBMET01777 0.05 0.03 DBMET00328 | DBMET01777 | |
| 0.022 | 0.027 | 0.034 | Uridine phosphorylase inhibitor | 0.034 0.015 DBMET00328 | DBMET00328 | |
| 0.067 | 0.072 | 0.091 | Keratolytic | 0.091 0.037 DBMET01777 0.087 0.041 DBMET00328 | DBMET01777 | |
| 0.032 | 0.037 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.013 DBMET01777 0.034 0.032 DBMET00328 | DBMET01777 | |
| 0.073 | 0.079 | 0.087 | Myeloperoxidase inhibitor | 0.087 0.054 DBMET01777 | DBMET01777 | |
| 0.033 | 0.039 | 0.05 | Membrane dipeptidase inhibitor | 0.039 0.028 DBMET01777 0.05 0.015 DBMET00328 | DBMET00328 | |
| 0.051 | 0.057 | 0.076 | Cannabinoid CB1 receptor antagonist | 0.076 0.029 DBMET01777 | DBMET01777 | |
| 0.081 | 0.088 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.09 0.071 DBMET01777 0.115 0.035 DBMET00328 | DBMET00328 | |
| 0.046 | 0.053 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.031 DBMET01777 0.052 0.04 DBMET00328 | DBMET01777 | |
| 0.048 | 0.056 | 0.064 | Fatty acid synthase inhibitor | 0.064 0.031 DBMET01777 | DBMET01777 | |
| 0.025 | 0.032 | 0.071 | Sirtuin 2 inhibitor | 0.071 0.007 DBMET01777 | DBMET01777 | |
| 0.024 | 0.032 | 0.032 | Glucosylceramidase stimulant | 0.032 0.009 DBMET01777 0.029 0.013 DBMET00328 | DBMET01777 | |
| 0.069 | 0.076 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.033 DBMET01777 | DBMET01777 | |
| 0.025 | 0.033 | 0.06 | Potassium channel subfamily K member 3 blocker | 0.06 0.01 DBMET01777 | DBMET01777 | |
| 0.094 | 0.102 | 0.285 | Amylase inhibitor | 0.285 0.02 DBMET00328 | DBMET00328 | |
| 0.052 | 0.062 | 0.079 | NMDA receptor agonist | 0.079 0.03 DBMET01777 0.062 0.044 DBMET00328 | DBMET01777 | |
| 0.137 | 0.147 | 0.147 | Aryl hydrocarbon receptor agonist | 0.147 0.138 DBMET01777 0.145 0.14 DBMET00328 | DBMET01777 | |
| 0.033 | 0.043 | 0.052 | Histone deacetylase 9 inhibitor | 0.052 0.015 DBMET01777 | DBMET01777 | |
| 0.057 | 0.067 | 0.088 | Potassium channel (ATP-sensitive) blocker | 0.088 0.022 DBMET01777 | DBMET01777 | |
| 0.039 | 0.049 | 0.041 | Heme oxygenase inhibitor | 0.041 0.037 DBMET00328 | DBMET00328 | |
| 0.016 | 0.026 | 0.027 | Methylmalonyl-CoA mutase inhibitor | 0.027 0.003 DBMET00328 | DBMET00328 | |
| 0.036 | 0.047 | 0.066 | AICAR transformylase inhibitor | 0.053 0.019 DBMET01777 0.066 0.011 DBMET00328 | DBMET00328 | |
| 0.101 | 0.112 | 0.169 | NADPH oxidase inhibitor | 0.128 0.073 DBMET01777 0.169 0.045 DBMET00328 | DBMET00328 | |
| 0.022 | 0.033 | 0.029 | Complement factor 1s inhibitor | 0.026 0.016 DBMET01777 0.029 0.01 DBMET00328 | DBMET00328 | |
| 0.005 | 0.016 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00328 | DBMET00328 | |
| 0.03 | 0.042 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.061 0.01 DBMET00328 | DBMET00328 | |
| 0.034 | 0.046 | 0.055 | Histamine H2 receptor agonist | 0.053 0.019 DBMET01777 0.055 0.018 DBMET00328 | DBMET00328 | |
| 0.066 | 0.078 | 0.084 | Calcium antagonist | 0.084 0.06 DBMET00328 | DBMET00328 | |
| 0.08 | 0.092 | 0.146 | Interleukin 1 beta converting enzyme inhibitor | 0.118 0.037 DBMET01777 0.146 0.019 DBMET00328 | DBMET00328 | |
| 0.081 | 0.094 | 0.105 | Expectorant | 0.093 0.077 DBMET01777 0.105 0.063 DBMET00328 | DBMET00328 | |
| 0.008 | 0.021 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 DBMET01777 | DBMET01777 | |
| 0.044 | 0.056 | 0.278 | Argininosuccinate synthase inhibitor | 0.278 0.004 DBMET00328 | DBMET00328 | |
| 0.059 | 0.073 | 0.118 | Epoxide hydrolase inhibitor | 0.118 0.018 DBMET01777 | DBMET01777 | |
| 0.028 | 0.041 | 0.052 | Potassium channel KCNQ activator | 0.052 0.015 DBMET01777 | DBMET01777 | |
| 0.028 | 0.041 | 0.052 | Delayed rectifier potassium channel activator | 0.052 0.015 DBMET01777 | DBMET01777 | |
| 0.049 | 0.063 | 0.076 | Cyclin D1 inhibitor | 0.076 0.022 DBMET00328 | DBMET00328 | |
| 0.033 | 0.048 | 0.099 | Glycine transporter 2 inhibitor | 0.099 0.013 DBMET01777 | DBMET01777 | |
| 0.022 | 0.038 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.023 DBMET01777 | DBMET01777 | |
| 0.117 | 0.132 | 0.149 | Neuropeptide Y1 antagonist | 0.149 0.067 DBMET01777 0.124 0.115 DBMET00328 | DBMET01777 | |
| 0.032 | 0.048 | 0.043 | Purinergic P2Y antagonist | 0.043 0.033 DBMET01777 | DBMET01777 | |
| 0.023 | 0.039 | 0.031 | Hedgehog signaling activator | 0.031 0.012 DBMET00328 | DBMET00328 | |
| 0.033 | 0.05 | 0.07 | Adenosine deaminase inhibitor | 0.07 0.014 DBMET00328 | DBMET00328 | |
| 0.088 | 0.104 | 0.137 | Alkylator | 0.101 0.087 DBMET01777 0.137 0.054 DBMET00328 | DBMET00328 | |
| 0.034 | 0.05 | 0.046 | Glycine transporter inhibitor | 0.046 0.035 DBMET01777 | DBMET01777 | |
| 0.051 | 0.068 | 0.273 | Phosphofructokinase-1 inhibitor | 0.273 0.006 DBMET00328 | DBMET00328 | |
| 0.008 | 0.025 | 0.013 | Adenosine A2a receptor agonist | 0.013 0.012 DBMET01777 | DBMET01777 | |
| 0.156 | 0.173 | 0.178 | MAP-kinase-activated kinase 5 inhibitor | 0.178 0.135 DBMET01777 | DBMET01777 | |
| 0.046 | 0.063 | 0.072 | Dihydroorotate oxidase inhibitor | 0.072 0.016 DBMET00328 | DBMET00328 | |
| 0.072 | 0.09 | 0.1 | MAO A inhibitor | 0.1 0.064 DBMET01777 | DBMET01777 | |
| 0.029 | 0.047 | 0.057 | Dihydropteroate synthase inhibitor | 0.057 0.013 DBMET01777 | DBMET01777 | |
| 0.045 | 0.063 | 0.07 | Glucosylceramidase inhibitor | 0.052 0.044 DBMET01777 0.07 0.022 DBMET00328 | DBMET00328 | |
| 0.057 | 0.075 | 0.063 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET00328 | DBMET00328 | |
| 0.016 | 0.034 | 0.029 | CYP24 inhibitor | 0.029 0.011 DBMET01777 | DBMET01777 | |
| 0.015 | 0.033 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.014 DBMET01777 | DBMET01777 | |
| 0.019 | 0.038 | 0.024 | Thyroid hormone agonist | 0.024 0.022 DBMET01777 | DBMET01777 | |
| 0.008 | 0.027 | 0.024 | Microsomal triglyceride transfer protein inhibitor | 0.024 0.005 DBMET01777 | DBMET01777 | |
| 0.043 | 0.062 | 0.11 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET01777 0.11 0.005 DBMET00328 | DBMET00328 | |
| 0.045 | 0.065 | 0.162 | Carbamoyl phosphate synthetase inhibitor | 0.162 0.01 DBMET00328 | DBMET00328 | |
| 0.039 | 0.06 | 0.055 | Bombesin 2 receptor antagonist | 0.055 0.028 DBMET01777 | DBMET01777 | |
| 0.029 | 0.051 | 0.06 | Dopamine D5 agonist | 0.06 0.012 DBMET00328 | DBMET00328 | |
| 0.046 | 0.068 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.044 DBMET01777 | DBMET01777 | |
| 0.029 | 0.051 | 0.068 | GABA uptake inhibitor | 0.068 0.008 DBMET00328 | DBMET00328 | |
| 0.036 | 0.058 | 0.045 | Transforming growth factor beta 1 antagonist | 0.045 0.04 DBMET01777 | DBMET01777 | |
| 0.055 | 0.078 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.039 DBMET00328 | DBMET00328 | |
| 0.044 | 0.068 | 0.057 | Androgen agonist | 0.057 0.045 DBMET00328 | DBMET00328 | |
| 0.008 | 0.032 | 0.018 | Egl nine homolog 1 inhibitor | 0.018 0.006 DBMET01777 | DBMET01777 | |
| 0.043 | 0.067 | 0.052 | Sphingosine kinase 2 inhibitor | 0.052 0.044 DBMET01777 0.052 0.044 DBMET00328 | DBMET00328 | |
| 0.011 | 0.036 | 0.017 | Acetyl-CoA carboxylase 1 inhibitor | 0.017 0.015 DBMET01777 | DBMET01777 | |
| 0.065 | 0.09 | 0.087 | GABA B receptor agonist | 0.07 0.068 DBMET01777 0.087 0.03 DBMET00328 | DBMET00328 | |
| 0.048 | 0.074 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 DBMET00328 | DBMET00328 | |
| 0.031 | 0.057 | 0.038 | Vanilloid 3 antagonist | 0.038 0.026 DBMET00328 | DBMET00328 | |
| 0.068 | 0.094 | 0.102 | Caspase 7 inhibitor | 0.082 0.057 DBMET01777 0.102 0.026 DBMET00328 | DBMET00328 | |
| 0.025 | 0.052 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.012 DBMET01777 0.035 0.021 DBMET00328 | DBMET01777 | |
| 0.075 | 0.102 | 0.096 | Carbonic anhydrase III inhibitor | 0.096 0.067 DBMET00328 | DBMET00328 | |
| 0.053 | 0.08 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.051 DBMET01777 | DBMET01777 | |
| 0.024 | 0.052 | 0.049 | Histone deacetylase 7 inhibitor | 0.049 0.018 DBMET01777 | DBMET01777 | |
| 0.042 | 0.069 | 0.066 | Factor III inhibitor | 0.066 0.013 DBMET01777 | DBMET01777 | |
| 0.108 | 0.135 | 0.138 | Farnesoid X receptor antagonist | 0.138 0.069 DBMET01777 | DBMET01777 | |
| 0.119 | 0.147 | 0.143 | Tumour necrosis factor antagonist | 0.143 0.11 DBMET01777 | DBMET01777 | |
| 0.007 | 0.035 | 0.012 | Melatonin 2 antagonist | 0.012 0.008 DBMET01777 | DBMET01777 | |
| 0.058 | 0.086 | 0.091 | Adenosine A3 receptor antagonist | 0.091 0.032 DBMET01777 | DBMET01777 | |
| 0.063 | 0.091 | 0.135 | Chymotrypsin inhibitor | 0.074 0.064 DBMET01777 0.135 0.021 DBMET00328 | DBMET00328 | |
| 0.027 | 0.056 | 0.042 | Integrin alpha2 antagonist | 0.042 0.018 DBMET01777 | DBMET01777 | |
| 0.042 | 0.072 | 0.057 | Thromboxane synthase inhibitor | 0.057 0.033 DBMET01777 | DBMET01777 | |
| 0.024 | 0.054 | 0.042 | CC chemokine 3 receptor antagonist | 0.042 0.029 DBMET01777 | DBMET01777 | |
| 0.043 | 0.074 | 0.069 | Calcium channel T-type blocker | 0.069 0.029 DBMET01777 | DBMET01777 | |
| 0.032 | 0.064 | 0.058 | Kainate receptor agonist | 0.058 0.008 DBMET00328 | DBMET00328 | |
| 0.013 | 0.045 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.012 DBMET00328 | DBMET00328 | |
| 0.018 | 0.049 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.02 DBMET01777 | DBMET01777 | |
| 0.099 | 0.132 | 0.107 | DNA repair enzyme inhibitor | 0.107 0.104 DBMET01777 0.107 0.103 DBMET00328 | DBMET00328 | |
| 0.01 | 0.043 | 0.023 | Telomerase stimulant | 0.023 0.005 DBMET00328 | DBMET00328 | |
| 0.07 | 0.103 | 0.091 | mTOR complex 2 inhibitor | 0.086 0.056 DBMET01777 0.091 0.046 DBMET00328 | DBMET00328 | |
| 0.019 | 0.053 | 0.024 | Thymidine phosphorylase inhibitor | 0.024 0.022 DBMET00328 | DBMET00328 | |
| 0.008 | 0.042 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET00328 | DBMET00328 | |
| 0.008 | 0.042 | 0.029 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET00328 | DBMET00328 | |
| 0.017 | 0.051 | 0.03 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.022 DBMET01777 | DBMET01777 | |
| 0.058 | 0.092 | 0.066 | MDM2 inhibitor | 0.066 0.051 DBMET00328 | DBMET00328 | |
| 0.034 | 0.068 | 0.041 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET00328 | DBMET00328 | |
| 0.028 | 0.062 | 0.058 | Glutamate (mGluR8) agonist | 0.058 0.008 DBMET00328 | DBMET00328 | |
| 0.046 | 0.08 | 0.064 | 5 Hydroxytryptamine 3A antagonist | 0.064 0.05 DBMET01777 | DBMET01777 | |
| 0.049 | 0.083 | 0.059 | Aryl hydrocarbon receptor antagonist | 0.059 0.056 DBMET01777 | DBMET01777 | |
| 0.018 | 0.053 | 0.027 | Peptide deformylase inhibitor | 0.027 0.025 DBMET00328 | DBMET00328 | |
| 0.033 | 0.068 | 0.064 | Dihydroorotate dehydrogenase inhibitor | 0.064 0.025 DBMET01777 | DBMET01777 | |
| 0.023 | 0.059 | 0.048 | Carbonic anhydrase IV inhibitor | 0.048 0.026 DBMET01777 | DBMET01777 | |
| 0.183 | 0.22 | 0.22 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.22 0.116 DBMET01777 | DBMET01777 | |
| 0.031 | 0.068 | 0.17 | Ornithine carbamoyltransferase inhibitor | 0.17 0.008 DBMET00328 | DBMET00328 | |
| 0.071 | 0.109 | 0.1 | Polo-like kinase-1 inhibitor | 0.1 0.045 DBMET01777 | DBMET01777 | |
| 0.047 | 0.085 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.063 0.034 DBMET01777 | DBMET01777 | |
| 0.067 | 0.106 | 0.121 | Potassium channel activator | 0.121 0.031 DBMET01777 | DBMET01777 | |
| 0.093 | 0.133 | 0.161 | Histone deacetylase SIRT1 inhibitor | 0.161 0.053 DBMET01777 | DBMET01777 | |
| 0.062 | 0.102 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 DBMET01777 | DBMET01777 | |
| 0.01 | 0.05 | 0.058 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.058 0.007 DBMET00328 | DBMET00328 | |
| 0.026 | 0.066 | 0.073 | Phosphorylase inhibitor | 0.073 0.019 DBMET01777 | DBMET01777 | |
| 0.053 | 0.093 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DBMET00328 | DBMET00328 | |
| 0.019 | 0.059 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET00328 | DBMET00328 | |
| 0.016 | 0.057 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.01 DBMET00328 | DBMET00328 | |
| 0.038 | 0.08 | 0.05 | CD45 antagonist | 0.05 0.035 DBMET01777 | DBMET01777 | |
| 0.048 | 0.09 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DBMET00328 | DBMET00328 | |
| 0.013 | 0.055 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET00328 | DBMET00328 | |
| 0.007 | 0.049 | 0.014 | Melatonin receptor 1A antagonist | 0.014 0.01 DBMET01777 | DBMET01777 | |
| 0.098 | 0.141 | 0.148 | Cell wall synthesis inhibitor | 0.148 0.068 DBMET00328 | DBMET00328 | |
| 0.043 | 0.086 | 0.067 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET01777 0.067 0.028 DBMET00328 | DBMET00328 | |
| 0.012 | 0.055 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET00328 | DBMET00328 | |
| 0.038 | 0.082 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.029 DBMET01777 | DBMET01777 | |
| 0.028 | 0.073 | 0.096 | Mannosidase inhibitor | 0.096 0.006 DBMET00328 | DBMET00328 | |
| 0.02 | 0.065 | 0.044 | Cathepsin L1 inhibitor | 0.044 0.024 DBMET01777 0.04 0.027 DBMET00328 | DBMET01777 | |
| 0.08 | 0.127 | 0.162 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET00328 | DBMET00328 | |
| 0.068 | 0.115 | 0.088 | Alpha 2c adrenoreceptor antagonist | 0.088 0.078 DBMET01777 | DBMET01777 | |
| 0.022 | 0.07 | 0.036 | Vascular adhesion protein 1 inhibitor | 0.036 0.032 DBMET01777 | DBMET01777 | |
| 0.038 | 0.086 | 0.054 | Heparanase inhibitor | 0.054 0.034 DBMET00328 | DBMET00328 | |
| 0.026 | 0.074 | 0.048 | Antimetabolite | 0.048 0.033 DBMET01777 0.046 0.034 DBMET00328 | DBMET01777 | |
| 0.004 | 0.053 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.008 DBMET00328 | DBMET00328 | |
| 0.184 | 0.234 | 0.268 | Alpha-glucosidase inhibitor | 0.268 0.177 DBMET01777 | DBMET01777 | |
| 0.048 | 0.099 | 0.079 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET00328 | DBMET00328 | |
| 0.022 | 0.074 | 0.043 | Carbonic anhydrase VII inhibitor | 0.043 0.036 DBMET01777 | DBMET01777 | |
| 0.084 | 0.137 | 0.146 | Cytokine production inhibitor | 0.146 0.065 DBMET01777 | DBMET01777 | |
| 0.032 | 0.085 | 0.062 | Cathepsin L inhibitor | 0.062 0.036 DBMET01777 0.062 0.036 DBMET00328 | DBMET00328 | |
| 0.043 | 0.097 | 0.156 | Histidine decarboxylase inhibitor | 0.156 0.019 DBMET00328 | DBMET00328 | |
| 0.008 | 0.063 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET00328 | DBMET00328 | |
| 0.043 | 0.097 | 0.059 | 5 Hydroxytryptamine 3 agonist | 0.059 0.05 DBMET00328 | DBMET00328 | |
| 0.012 | 0.067 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.014 DBMET00328 | DBMET00328 | |
| 0.034 | 0.089 | 0.059 | HCV NS3/NS4A protease inhibitor | 0.059 0.022 DBMET00328 | DBMET00328 | |
| 0.005 | 0.06 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET00328 | DBMET00328 | |
| 0.03 | 0.087 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET00328 | DBMET00328 | |
| 0.025 | 0.082 | 0.043 | Acetyl-CoA carboxylase inhibitor | 0.043 0.027 DBMET01777 | DBMET01777 | |
| 0.007 | 0.065 | 0.018 | Thromboxane A2 agonist | 0.018 0.007 DBMET00328 | DBMET00328 | |
| 0.107 | 0.166 | 0.12 | Death-associated protein kinase 1 inhibitor | 0.12 0.115 DBMET01777 | DBMET01777 | |
| 0.046 | 0.108 | 0.101 | Thrombin inhibitor | 0.101 0.025 DBMET00328 | DBMET00328 | |
| 0.023 | 0.084 | 0.053 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.039 DBMET00328 | DBMET00328 | |
| 0.065 | 0.128 | 0.083 | DNA directed RNA polymerase inhibitor | 0.083 0.08 DBMET01777 | DBMET01777 | |
| 0.008 | 0.072 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00328 | DBMET00328 | |
| 0.02 | 0.084 | 0.041 | DNA gyrase subunit B inhibitor | 0.041 0.022 DBMET01777 | DBMET01777 | |
| 0.01 | 0.074 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET00328 | DBMET00328 | |
| 0.022 | 0.087 | 0.053 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET00328 | DBMET00328 | |
| 0.013 | 0.08 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET00328 | DBMET00328 | |
| 0.114 | 0.182 | 0.198 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET00328 | DBMET00328 | |
| 0.009 | 0.079 | 0.021 | Integrin alphaVbeta1 antagonist | 0.021 0.011 DBMET01777 | DBMET01777 | |
| 0.143 | 0.213 | 0.178 | Peptidyltransferase inhibitor | 0.178 0.132 DBMET01777 | DBMET01777 | |
| 0.114 | 0.184 | 0.154 | Insulin sensitizer | 0.154 0.128 DBMET00328 | DBMET00328 | |
| 0.023 | 0.093 | 0.053 | Stearoyl-CoA desaturase inhibitor | 0.053 0.021 DBMET01777 | DBMET01777 | |
| 0.013 | 0.083 | 0.029 | Trypsin I inhibitor | 0.029 0.027 DBMET00328 | DBMET00328 | |
| 0.08 | 0.151 | 0.106 | Sodium channel blocker | 0.106 0.103 DBMET01777 | DBMET01777 | |
| 0.024 | 0.096 | 0.13 | Xanthine dehydrogenase inhibitor | 0.13 0.009 DBMET00328 | DBMET00328 | |
| 0.014 | 0.086 | 0.028 | LFA antagonist | 0.028 0.018 DBMET01777 | DBMET01777 | |
| 0.087 | 0.161 | 0.136 | Sphingosine 1-phosphate receptor 2 agonist | 0.136 0.036 DBMET01777 | DBMET01777 | |
| 0.018 | 0.092 | 0.036 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET00328 | DBMET00328 | |
| 0.024 | 0.1 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.036 DBMET00328 | DBMET00328 | |
| 0.075 | 0.151 | 0.11 | Nav1.5 sodium channel blocker | 0.11 0.068 DBMET01777 | DBMET01777 | |
| 0.039 | 0.115 | 0.119 | Carbonic anhydrase XIII inhibitor | 0.119 0.03 DBMET00328 | DBMET00328 | |
| 0.014 | 0.091 | 0.035 | Trypsin II inhibitor | 0.035 0.016 DBMET00328 | DBMET00328 | |
| 0.028 | 0.106 | 0.053 | Human rhinovirus A protease inhibitor | 0.053 0.04 DBMET00328 | DBMET00328 | |
| 0.01 | 0.089 | 0.021 | Elastase 2A inhibitor | 0.021 0.016 DBMET00328 | DBMET00328 | |
| 0.01 | 0.089 | 0.021 | Elastase 2 inhibitor | 0.021 0.016 DBMET00328 | DBMET00328 | |
| 0.012 | 0.092 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.015 DBMET01777 | DBMET01777 | |
| 0.046 | 0.128 | 0.083 | Trypsin inhibitor | 0.083 0.025 DBMET00328 | DBMET00328 | |
| 0.105 | 0.19 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.112 DBMET01777 | DBMET01777 | |
| 0.009 | 0.098 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET00328 | DBMET00328 | |
| 0.062 | 0.151 | 0.198 | ABCA1 expression enhancer | 0.198 0.009 DBMET00328 | DBMET00328 | |
| 0.028 | 0.124 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.044 DBMET01777 | DBMET01777 | |
| 0.006 | 0.102 | 0.018 | Nicotinic alpha4 receptor agonist | 0.018 0.009 DBMET00328 | DBMET00328 | |
| 0.01 | 0.107 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET00328 | DBMET00328 | |
| 0.011 | 0.111 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.026 DBMET00328 | DBMET00328 | |
| 0.003 | 0.104 | 0.015 | Immunosuppressant Cyclosporine-like | 0.015 0.005 DBMET00328 | DBMET00328 | |
| 0.024 | 0.13 | 0.069 | p38 MAP kinase inhibitor | 0.069 0.046 DBMET01777 | DBMET01777 | |
| 0.032 | 0.138 | 0.5 | Cathepsin B inhibitor | 0.051 0.047 DBMET01777 0.5 0.003 DBMET00328 | DBMET00328 | |
| 0.059 | 0.17 | 0.085 | Ca(v)3.1 blocker | 0.085 0.047 DBMET01777 0.078 0.065 DBMET00328 | DBMET01777 | |
| 0.009 | 0.121 | 0.042 | Protease activated receptor 1 antagonist | 0.042 0.036 DBMET01777 | DBMET01777 | |
| 0.032 | 0.145 | 0.177 | Amidase inhibitor | 0.177 0.007 DBMET00328 | DBMET00328 | |
| 0.152 | 0.268 | 0.358 | Apoptosis antagonist | 0.358 0.052 DBMET00328 | DBMET00328 | |
| 0.114 | 0.231 | 0.144 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.112 DBMET01777 | DBMET01777 | |
| 0.044 | 0.161 | 0.085 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.085 0.063 DBMET01777 | DBMET01777 | |
| 0.055 | 0.188 | 0.086 | Xanthine oxidase inhibitor | 0.086 0.079 DBMET00328 | DBMET00328 | |
| 0.017 | 0.153 | 0.031 | Elastase 3A inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.017 | 0.153 | 0.031 | Elastase 2B inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.017 | 0.153 | 0.031 | Elastase 3B inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.007 | 0.151 | 0.62 | Calpain 1 inhibitor | 0.62 0.002 DBMET00328 | DBMET00328 | |
| 0.028 | 0.185 | 0.064 | Histone deacetylase SIRT2 inhibitor | 0.064 0.063 DBMET01777 | DBMET01777 | |
| 0.009 | 0.166 | 0.036 | Protocollagen prolyl hydroxylase inhibitor | 0.036 0.009 DBMET01777 | DBMET01777 | |
| 0.05 | 0.218 | 0.122 | Histone deacetylase class III inhibitor | 0.122 0.068 DBMET01777 | DBMET01777 | |
| 0.031 | 0.199 | 0.08 | Rho-associated kinase II inhibitor | 0.08 0.045 DBMET01777 | DBMET01777 | |
| 0.044 | 0.226 | 0.122 | Factor XII inhibitor | 0.122 0.023 DBMET00328 | DBMET00328 | |
| 0.06 | 0.244 | 0.128 | Neurotrophic factor | 0.128 0.083 DBMET00328 | DBMET00328 | |
| 0.035 | 0.227 | 0.13 | Protease inhibitor | 0.13 0.041 DBMET00328 | DBMET00328 | |
| 0.046 | 0.238 | 0.104 | M17 leucyl aminopeptidase inhibitor | 0.104 0.096 DBMET01777 | DBMET01777 | |
| 0.03 | 0.223 | 0.059 | Ca(v)3.2 blocker | 0.059 0.039 DBMET01777 | DBMET01777 | |
| 0.061 | 0.255 | 0.116 | Folate antagonist | 0.116 0.042 DBMET01777 | DBMET01777 | |
| 0.065 | 0.261 | 0.534 | Factor V inhibitor | 0.534 0.001 DBMET00328 | DBMET00328 | |
| 0.034 | 0.234 | 0.211 | Caspase 9 inhibitor | 0.211 0.004 DBMET00328 | DBMET00328 | |
| 0.025 | 0.225 | 0.12 | Elastase 1 inhibitor | 0.12 0.012 DBMET00328 | DBMET00328 | |
| 0.025 | 0.229 | 0.063 | Sirtuin 1 inhibitor | 0.063 0.055 DBMET01777 | DBMET01777 | |
| 0.017 | 0.225 | 0.188 | Plasmin inhibitor | 0.188 0.007 DBMET00328 | DBMET00328 | |
| 0.128 | 0.339 | 0.263 | Antibacterial | 0.263 0.165 DBMET00328 | DBMET00328 | |
| 0.006 | 0.221 | 0.027 | Melatonin antagonist | 0.027 0.022 DBMET01777 | DBMET01777 | |
| 0.001 | 0.218 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 DBMET00328 | DBMET00328 | |
| 0.04 | 0.272 | 0.08 | Falcipain inhibitor | 0.08 0.074 DBMET00328 | DBMET00328 | |
| 0.008 | 0.242 | 0.105 | Cathepsin K inhibitor | 0.105 0.005 DBMET00328 | DBMET00328 | |
| 0.015 | 0.256 | 0.173 | Protein 50S ribosomal subunit inhibitor | 0.173 0.005 DBMET00328 | DBMET00328 | |
| 0.007 | 0.264 | 0.053 | Caspase 2 inhibitor | 0.053 0.011 DBMET00328 | DBMET00328 | |
| 0.019 | 0.278 | 0.142 | DNA gyrase inhibitor | 0.142 0.009 DBMET01777 | DBMET01777 | |
| 0.043 | 0.31 | 0.103 | Thioredoxin reductase inhibitor | 0.103 0.026 DBMET00328 | DBMET00328 | |
| 0.014 | 0.3 | 0.029 | DNA topoisomerase IV inhibitor | 0.029 0.022 DBMET01777 | DBMET01777 | |
| 0.016 | 0.307 | 0.107 | Lipase inhibitor | 0.107 0.024 DBMET00328 | DBMET00328 | |
| 0.012 | 0.304 | 0.096 | Plasminogen activator inhibitor | 0.096 0.018 DBMET00328 | DBMET00328 | |
| 0.1 | 0.429 | 0.372 | Caspase 3 stimulant | 0.372 0.052 DBMET00328 | DBMET00328 | |
| 0.044 | 0.383 | 0.448 | 3C-Like protease (SARS coronavirus) inhibitor | 0.448 0.002 DBMET00328 | DBMET00328 | |
| 0.045 | 0.4 | 0.157 | Nitric oxide antagonist | 0.157 0.09 DBMET00328 | DBMET00328 | |
| 0.002 | 0.43 | 0.073 | 3C-Like protease (MERS coronavirus) inhibitor | 0.073 0.001 DBMET00328 | DBMET00328 | |
| 0.038 | 0.467 | 0.1 | CDK3/cyclin E inhibitor | 0.1 0.088 DBMET01777 | DBMET01777 | |
| 0.007 | 0.59 | 0.093 | CDC25B inhibitor | 0.093 0.019 DBMET00328 | DBMET00328 | |
| 0.023 | 0.626 | 0.086 | Interleukin 5 antagonist | 0.086 0.061 DBMET00328 | DBMET00328 | |
| 0.005 | 0.625 | 0.038 | Caspase 6 inhibitor | 0.038 0.009 DBMET00328 | DBMET00328 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |